Bristol-Myers Squibb and Nanocopoeia Face Off in Pivotal Pharmaceutical Patent Dispute
The legal battle between Bristol-Myers Squibb Co. and Nanocopoeia, LLC continues to garner industry attention. The case is formally known as Bristol-Myers Squibb Co. v. Nanocopoeia, LLC, No. 22-cv-1283, 2023 WL 2867945 (D. Minn. Apr. 10, 2023) (Menendez, J.). This dispute involves the drug product Sprycel® (dasatinib) and two relevant U.S. patents – Nos. 7,491,725…